Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05678634 · ClinicalTrials.gov registry record · NA

Optimizing Feedback-based Learning in Children With Developmental Language Disorder

A NA study of Developmental Language Disorder, sponsored by MGH Institute of Health Professions.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05678634: Recruiting NA study of Developmental Language Disorder, sponsored by MGH Institute of Health Professions.

NCT05678634 is a NA study of Developmental Language Disorder that is actively recruiting participants, run by MGH Institute of Health Professions. The registered enrollment target is 100 participants, below the 177-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05678634, a NA study of Developmental Language Disorder, is actively recruiting participants, sponsored by MGH Institute of Health Professions.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This project aims to optimize a critical but understudied ingredient of language intervention provided to children with developmental language disorder (DLD) - feedback. The project will bridge a gap between previous findings in our lab of inefficient feedback processing in DLD and clinical practice by identifying the conditions under which feedback-based learning can be improved in DLD. The investigators hypothesize that the effectiveness of feedback can be significantly enhanced for children with DLD when it is tailored to their unique learning strengths. The rationale for this project is based on evidence that feedback-based learning can be improved by enhancing the dominance of an intact learning system. The project will achieve its aim by manipulating (1) the timing of the feedback (immediate vs. delayed) and (2) the level of the learner's involvement in error correction dictated by feedback (active vs. passive correction). Aim 1 will determine the effect of manipulating feedback timing on learning in 140 school-age children (8-12 years) with DLD. While immediate feedback is processed by the striatum, which is also implicated in implicit learning, delaying the feedback by a few seconds shifts feedback processing to the mediate temporal lobe (MTL)-based declarative learning system. Evidence that delaying feedback improves learning in DLD would support the hypothesis of the implicit deficit theory that intervention should capitalize on declarative learning mechanisms. The project will test a novel alternative feedback-learning parity hypothesis whereby feedback-based learning is optimized when the timing of the feedback is aligned with the dominant learning system at a given time (i.e., immediate feedback during striatal-based probabilistic learning; delayed feedback during MTL-based declarative learning). Within the same group of children, Aim 2 will compare feedback-based learning in children with DLD when feedback (a) prompts active self-correction or (b) pass

Primary Outcome

Accuracy on a two-choice paired-associate test following each of the learning conditions. The structure of a test trial will be similar to the structure of a task trial but it will not include feedback. This measure will evaluate learning outcomes.

Interventions

  • BEHAVIORAL Declarative learning with immediate feedback
  • BEHAVIORAL Declarative learning with delayed feedback
  • BEHAVIORAL Probabilistic learning with immediate feedback
  • BEHAVIORAL Probabilistic learning with delayed feedback
  • BEHAVIORAL Word learning task with active feedback

Study Locations (1)

Massachusetts

  • MGH Institute of Health Professions - Boston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-07-20
Est. Completion 2027-10-01
Phase NA

What NCT05678634 shows while recruiting

NCT05678634 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 177-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (44% lower).

The record links to 1 condition, with Developmental Language Disorder appearing as the primary indexed condition, and to 5 interventions - of which Declarative learning with immediate feedback is the first listed.

NCT05678634 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05678634 about?

NCT05678634 is a clinical study titled "Optimizing Feedback-based Learning in Children With Developmental Language Disorder". This project aims to optimize a critical but understudied ingredient of language intervention provided to children with developmental language disorder (DLD) - feedback. The project will bridge a gap between previous findings in our lab of inefficient feedback processing in DLD and clinical practice...

What is the current status of trial NCT05678634?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-07-20. Estimated completion is 2027-10-01.

What conditions does trial NCT05678634 study?

This clinical trial studies the following conditions: Developmental Language Disorder.

What interventions are being tested in trial NCT05678634?

The interventions under investigation include: Declarative learning with immediate feedback (BEHAVIORAL), Declarative learning with delayed feedback (BEHAVIORAL), Probabilistic learning with immediate feedback (BEHAVIORAL), Probabilistic learning with delayed feedback (BEHAVIORAL), Word learning task with active feedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT05678634?

This trial is sponsored by MGH Institute of Health Professions, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05678634 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Developmental Language Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05678634's enrollment target sits among peer trials

100 11th of 17 higher than 6 of 17 other Developmental Language Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Developmental Language Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05678634, the US trial registry maintained by the National Library of Medicine. NCT05678634 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.